<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81127</article-id><article-id pub-id-type="doi">10.7554/eLife.81127</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: impact of risk factors and treatment modalities on survivorship</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-284734"><name><surname>Raad</surname><given-names>Issam I</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284730"><name><surname>Hachem</surname><given-names>Ray</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287102"><name><surname>Masayuki</surname><given-names>Nigo</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287103"><name><surname>Datoguia</surname><given-names>Tarcila</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284727"><name><surname>Dagher</surname><given-names>Hiba</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284729"><name><surname>Jiang</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287104"><name><surname>Subbiah</surname><given-names>Vivek</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287105"><name><surname>Siddiqui</surname><given-names>Bilal</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287098"><name><surname>Bayle</surname><given-names>Arnaud</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287445"><name><surname>Somer</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287446"><name><surname>Fern√°ndez Cruz</surname><given-names>Ana</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287110"><name><surname>Gorak</surname><given-names>Edward</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287114"><name><surname>Bhinder</surname><given-names>Arvinder</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287115"><name><surname>Nobuyoshi</surname><given-names>Mori</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8815-5135</contrib-id><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287116"><name><surname>Hamerschlak</surname><given-names>Nelson</given-names></name><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287113"><name><surname>Shelanski</surname><given-names>Samuel</given-names></name><xref ref-type="aff" rid="aff14">14</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287400"><name><surname>Dragovich</surname><given-names>Tomislav</given-names></name><xref ref-type="aff" rid="aff15">15</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287401"><name><surname>Vong</surname><given-names>Elise</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8870-1391</contrib-id><xref ref-type="aff" rid="aff16">16</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287402"><name><surname>Fakhreddine</surname><given-names>Suha</given-names></name><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287403"><name><surname>Pierre</surname><given-names>Abi Hanna</given-names></name><xref ref-type="aff" rid="aff17">17</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287404"><name><surname>Chemaly</surname><given-names>Roy F</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287405"><name><surname>Mulanovich</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287406"><name><surname>Adachi</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284732"><name><surname>Borjan</surname><given-names>Jovan</given-names></name><xref ref-type="aff" rid="aff18">18</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285523"><name><surname>Khawaja</surname><given-names>Fareed</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285518"><name><surname>Granwehr</surname><given-names>Bruno</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285519"><name><surname>John</surname><given-names>Teny</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285520"><name><surname>Yepez</surname><given-names>Eduardo</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287427"><name><surname>Torres</surname><given-names>Harrys</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287428"><name><surname>Ammakkanavar</surname><given-names>Natraj Reddy</given-names></name><xref ref-type="aff" rid="aff19">19</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287429"><name><surname>Yibirin</surname><given-names>Marcel</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285521"><name><surname>Reyes-Gibby</surname><given-names>Cielito</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4500-6476</contrib-id><xref ref-type="aff" rid="aff20">20</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285524"><name><surname>Pande</surname><given-names>Mala</given-names></name><xref ref-type="aff" rid="aff21">21</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285525"><name><surname>Ali</surname><given-names>Noman</given-names></name><xref ref-type="aff" rid="aff22">22</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-285526"><name><surname>Rojo</surname><given-names>Raniv</given-names></name><xref ref-type="aff" rid="aff23">23</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287430"><name><surname>Ali</surname><given-names>Shahnoor</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287431"><name><surname>Deeba</surname><given-names>Rita</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287432"><name><surname>Chaftari</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="aff24">24</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287433"><name><surname>Matsuo</surname><given-names>Takahiro</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287434"><name><surname>Ishikawa</surname><given-names>Kazuhiro</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287435"><name><surname>Hasegawa</surname><given-names>Ryo</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287436"><name><surname>Aguado-Noya</surname><given-names>Ram√≥n</given-names></name><xref ref-type="aff" rid="aff25">25</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287437"><name><surname>Garc√≠a‚Ä¨</surname><given-names>‚Ä™Alvaro</given-names></name><xref ref-type="aff" rid="aff26">26</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287438"><name><surname>Puchol</surname><given-names>Cristina Traseira</given-names></name><xref ref-type="aff" rid="aff25">25</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287439"><name><surname>Lee</surname><given-names>Dong-Gun¬†</given-names></name><xref ref-type="aff" rid="aff27">27</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287440"><name><surname>Slavin</surname><given-names>Monica</given-names></name><xref ref-type="aff" rid="aff28">28</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287441"><name><surname>Teh</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="aff28">28</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287453"><name><surname>Arias</surname><given-names>Cesar A</given-names></name><xref ref-type="aff" rid="aff29">29</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-287451"><name><surname>Oncology Discovery Effort (D3CODE) Team</surname><given-names>Data-Driven Determinants for COVID-19</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-139880"><name><surname>Dimitrios P. Kontoyiannis</surname><given-names>Prof.</given-names></name><xref ref-type="aff" rid="aff30">30</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284731"><name><surname>Malek</surname><given-names>Alexandre E</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-283327"><name><surname>Chaftari</surname><given-names>Anne-Marie</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8097-8452</contrib-id><xref ref-type="aff" rid="aff24">24</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Infectious Diseases</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Division of Infectious Diseases</institution>, <institution>The University of Texas Health Science Center at Houston</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution>Hospital Israelita Albert EinsteinUniversidade Metropolitana de Santos</institution>, <addr-line><named-content content-type="city">S√£o Paulo</named-content></addr-line>, <country>Brazil</country></aff><aff id="aff4"><institution content-type="dept">Department of Infectious Diseases, Infection Control and Employee Health</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution>UT MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution>Community Health Network</institution>, <addr-line><named-content content-type="city">Indiana</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution>Gustave Roussy, Universit√© Paris-Saclay</institution>, <addr-line><named-content content-type="city">Gustave Roussy, Universit√© Paris-Saclay</named-content></addr-line>, <country>France</country></aff><aff id="aff8"><institution>Cooper University Health Care</institution>, <addr-line><named-content content-type="city">Camden</named-content></addr-line>, <country>United States</country></aff><aff id="aff9"><institution>Unidad de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario</institution>, <addr-line><named-content content-type="city">Puerta de Hierro</named-content></addr-line>, <country>Spain</country></aff><aff id="aff10"><institution>Department of Hematology Oncology, Baptist Health</institution>, <addr-line><named-content content-type="city">Jacksonville</named-content></addr-line>, <country>United States</country></aff><aff id="aff11"><institution>Ohio Health</institution>, <addr-line><named-content content-type="city">Marion</named-content></addr-line>, <country>United States</country></aff><aff id="aff12"><institution>St. Luke's International Hospital</institution>, <addr-line><named-content content-type="city">Tokyo</named-content></addr-line>, <country>Japan</country></aff><aff id="aff13"><institution>Hospital Israelita Albert Einstein</institution>, <addr-line><named-content content-type="city">Sao Paulo</named-content></addr-line>, <country>Brazil</country></aff><aff id="aff14"><institution>Banner MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Greeley</named-content></addr-line>, <country>United States</country></aff><aff id="aff15"><institution>Banner MD Anderson</institution>, <addr-line><named-content content-type="city">Gilbert</named-content></addr-line>, <country>United States</country></aff><aff id="aff16"><institution>Tan Tock Seng Hospital</institution>, <addr-line><named-content content-type="city">Singapore</named-content></addr-line>, <country>Singapore</country></aff><aff id="aff17"><institution>Rafik Hariri University Hospital</institution>, <addr-line><named-content content-type="city">Beirut</named-content></addr-line>, <country>Lebanon</country></aff><aff id="aff18"><institution content-type="dept">Pharmacy Clinical Programs</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff19"><institution>Community Health Network</institution>, <addr-line><named-content content-type="city">Indianapolis</named-content></addr-line>, <country>United States</country></aff><aff id="aff20"><institution content-type="dept">Emergency Medicine-Research</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff21"><institution content-type="dept">Gastroenterology Research</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff22"><institution content-type="dept">Hospital Medicine</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff23"><institution content-type="dept">Breast Surgical Oncology</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff24"><institution content-type="dept">Department of Emergency Medicine</institution>, <institution>The University of Texas MD Anderson Cancer Center</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff25"><institution>Hospital Universitario Puerta de Hierro-Majadahonda</institution>, <addr-line><named-content content-type="city">Madrid</named-content></addr-line>, <country>Spain</country></aff><aff id="aff26"><institution>St. Lukes Hospital</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff27"><institution>The Catholic University of Korea</institution>, <addr-line><named-content content-type="city">Seoul</named-content></addr-line>, <country>Republic of Korea</country></aff><aff id="aff28"><institution>Peter MacCallum Cancer Centre</institution>, <addr-line><named-content content-type="city">Victoria</named-content></addr-line>, <country>Australia</country></aff><aff id="aff29"><institution>Houston Methodist</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, <country>United States</country></aff><aff id="aff30"><institution>The University of Texas MD Anderson Cancer Center,</institution>, <addr-line><named-content content-type="city">Houston</named-content></addr-line>, </aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-172863"><name><surname>Turajlic</surname><given-names>Samra</given-names></name><role>Reviewing editor</role><aff><institution>The Francis Crick Institute</institution>, <country>United Kingdom</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>achaftari@mdanderson.org</email> (AC);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>30</day><month>01</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e81127</elocation-id><history><date date-type="received"><day>24</day><month>06</month><year>2022</year></date><date date-type="accepted"><day>16</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement>¬© 2023, Raad et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Raad et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81127-v1.pdf"/><abstract><p><bold>Background:</bold> In this international multicenter study we aimed to determine the independent risk factors associated with increased 30-day mortality and the impact of cancer and novel treatment modalities in a large group of patients with and without cancer with COVID-19 from multiple countries.</p><p><bold>Methods:</bold> We retrospectively collected de-identified data on a cohort of patients with and without cancer diagnosed with COVID-19 between January and November 2020, from 16 international centers.</p><p><bold>Results:</bold> We analyzed 3966 COVID-19 confirmed patients, 1115 with cancer and 2851 nwithout cancer patients. Patients with cancer were more likely to be pancytopenic, and have a smoking history, pulmonary disorders, hypertension, diabetes mellitus, and corticosteroid use in the preceding two weeks (p‚â§0.01). In addition, they were more likely to present with higher inflammatory biomarkers (D-dimer, ferritin and procalcitonin), but were less likely to present with clinical symptoms (p‚â§0.01). By country-adjusted multivariable logistic regression analyses, cancer was not found to be an independent risk factor for 30-day mortality (p=0.18) whereas lymphopenia was independently associated with increased mortality in all patients, and in patients with cancer. Older age (‚â•65 years) was the strongest predictor of 30-day mortality in all patients(OR=4.47, p&lt;0.0001). Remdesivir was the only therapeutic agent independently associated with decreased 30-day mortality ()(OR=0.64, p=0.036). Among patients on low-flow oxygen at admission, patients who received remdesivir had a lower 30-day mortality rate than those who did not (5.9% vs 17.6%; p=0.03).</p><p><bold>Conclusions:</bold> Increased 30-day all-cause mortality from COVID-19 was not independently associated with cancer but was independently associated with lymphopenia often observed in hematolgic malignancy. Remdesivir, particularly in patients with cancer receiving low-flow oxygen, can reduce 30-day all-cause mortality.</p><p><bold>Funding:</bold> National Cancer Institute, National Institutes of Health.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Raad</surname><given-names>Issam I</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000098</institution-id><institution>NIH Clinical Center</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Raad</surname><given-names>Issam I</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: This study (Protocol # 2020-0437) was approved by the institutional review board at MD Anderson Cancer Center and the institutional review boards of the collaborating centers. A patient waiver of informed consent was obtained.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>We are unable to share the data given our restriction policy and the fact that this study includes data from 16 centers from the five continents and we have no agreement in place to share data.*Thank you for indicating that you are unable to make this data publicly available and providing some further information regarding this. Exceptions to our usual data sharing policy are subject to editorial approval, as per our data availability policy [https://submit.elifesciences.org/html/elife_author_instructions.html#policies]. To enable the editors to make an informed decision, please can you provide further information on the data sharing plan for your manuscript. This information should be added to your data availability statement (found in the Submission Information section of the submission form). Some of these points may already be covered, however please ensure that the statement covers the following:- Please provide an explanation of why the data cannot be shared.We are unable to share our data given the restrictive policy of our institution. We also do not have the permission to share data from the other institutions that participated in this study- Please describe how an interested researcher would be able to access the original data e.g. Who would they need to contact? Do they need to apply or submit a project proposal? If so, who would assess this proposal (e.g. a data access committee or IRB)? Are there any restrictions on who can access the data e.g. could commercial research be performed on the data?Given that this study involves data from 16 centers from the five continents, we have no agreement to share data.- Please provide any code or software that you have used to analyse the data.The analyses were performed using SAS version 9.3 (SAS Institute Inc., Cary, NC).- Please provide access to all materials and data for which the restrictions do not apply. For instance, would it be possible to share a deidentified version of the dataset? If not, would you be able to share processed version of the dataset e.g. an Excel sheet with numbers used to plot the graphs and charts in your manuscript?We are unable to share the data.</p></sec><supplementary-material><ext-link xlink:href="elife-81127-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>